AKTS
Aktis Oncology·NASDAQ
--
--(--)
--
--(--)
AKTS fundamentals
During Q4 2025, Aktis Oncology (AKTS) reported revenue of 1.87M, a YoY change of 100.43%. Net income was -15.14M, a YoY change of -25.56%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q4,2023 | Q4,2024 | Q4,2025 | TTM |
|---|
Start Date | Oct 1, 2023 | Oct 1, 2024 | Oct 1, 2025 | -- |
End Date | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 933.00K -- | 1.87M +100.43% | -- -- |
Operating Expenses | 10.01M -- | -- -- | -- -- | -- -- |
Selling, General and Administrative Expenses | 2.56M -- | -- -- | -- -- | -- -- |
General and Administrative Expenses | 8.88M -- | -- -- | -- -- | -- -- |
Research and Development Expenses | 7.45M -- | -- -- | -- -- | -- -- |
Operating Income | -10.01M -- | -- -- | -- -- | -- -- |
Non-Operating Income (Loss) | 1.59M -- | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | 800.00K -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | -611.00K -- | -- -- | -- -- | -- -- |
Net Interest Expense | -1.41M -- | -- -- | -- -- | -- -- |
Interest Income | 1.41M -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -8.41M -- | -12.06M -43.29% | -15.14M -25.56% | -- -- |
Net Income | -8.41M -- | -12.06M -43.29% | -15.14M -25.56% | -- -- |
Net Income Attributable to Owners of the Company | -8.41M -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -8.41M -- | -- -- | -- -- | -- -- |
Other Comprehensive Income | 135.00K -- | -84.00K -162.22% | 26.00K +130.95% | -- -- |
Total Comprehensive Income | -8.28M -- | -12.14M -46.64% | -15.11M -24.48% | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -8.28M -- | -- -- | -- -- | -- -- |
You can ask Aime
What factors drove the changes in Aktis Oncology's revenue and profit?What were the key takeaways from Aktis Oncology’s earnings call?What is the revenue and EPS growth rate for Aktis Oncology year over year?What is Aktis Oncology's gross profit margin?What is the market's earnings forecast for Aktis Oncology next quarter?Did Aktis Oncology beat or miss consensus estimates last quarter?What guidance did Aktis Oncology's management provide for the next earnings period?What does Aktis Oncology do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
